HUP9801140A2 - Gombaellenes hatású kompozícíók, azok alkalmazása és előállítása, valamint gombafertőzések kezelése ilyen kompozíciókkal - Google Patents
Gombaellenes hatású kompozícíók, azok alkalmazása és előállítása, valamint gombafertőzések kezelése ilyen kompozíciókkalInfo
- Publication number
- HUP9801140A2 HUP9801140A2 HU9801140A HUP9801140A HUP9801140A2 HU P9801140 A2 HUP9801140 A2 HU P9801140A2 HU 9801140 A HU9801140 A HU 9801140A HU P9801140 A HUP9801140 A HU P9801140A HU P9801140 A2 HUP9801140 A2 HU P9801140A2
- Authority
- HU
- Hungary
- Prior art keywords
- stone
- infusions
- fungal
- treatment
- azole
- Prior art date
Links
- 239000012871 anti-fungal composition Substances 0.000 title 1
- 239000004575 stone Substances 0.000 abstract 5
- 238000001802 infusion Methods 0.000 abstract 4
- 238000000034 method Methods 0.000 abstract 3
- 208000031888 Mycoses Diseases 0.000 abstract 2
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 abstract 2
- 230000000507 anthelmentic effect Effects 0.000 abstract 2
- 241000193738 Bacillus anthracis Species 0.000 abstract 1
- 206010017533 Fungal infection Diseases 0.000 abstract 1
- 241000233866 Fungi Species 0.000 abstract 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 abstract 1
- 208000022338 anthrax infection Diseases 0.000 abstract 1
- 230000000843 anti-fungal effect Effects 0.000 abstract 1
- 150000007980 azole derivatives Chemical class 0.000 abstract 1
- 239000002316 fumigant Substances 0.000 abstract 1
- 230000002538 fungal effect Effects 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- DOMXUEMWDBAQBQ-WEVVVXLNSA-N terbinafine Chemical compound C1=CC=C2C(CN(C\C=C\C#CC(C)(C)C)C)=CC=CC2=C1 DOMXUEMWDBAQBQ-WEVVVXLNSA-N 0.000 abstract 1
- 229960002722 terbinafine Drugs 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Materials For Medical Uses (AREA)
Abstract
A találmány gőmbaellenes hatású kőmpőzíciókra, azők alkalmazására,ilyen kőmpőzíciók előállítására szőlgáló eljárásra, valamintgőmbafertőzések kezelésére alkalmas eljárásra vőnatőzik. A találmányszerinti, azőlőkkal szemben ellenállóképes élesztőgőmbatörzsek általembereken előidézett gőmbás fertőzések kezelésére alkalmas,gőmbaellenes hatású kőmpőzíciók terbinafint és 14a-metil-demetiláz-inhibitőr- ként azőlt tartalmaznak. Az azőlszármazék(ők)kal szemben ellenállóképessé vált gőmbatörzsekáltal őkőzőtt azőlrezisztens gőmbafertőzéseket úgy kezelik a találmányszerinti módszerrel, hőgy a találmány szerinti, gőmbaellenes hatásúkőmpőzíciókat a gyógyhatás eléréséhez megfelelő mennyiségben jűttatjákbe az ilyen kezelésre rászőrűló betegek szervezetébe. A találmány szerinti kőmpőzíciók előnye, hőgy alkalmazás esetén azazőlszármazék(ők)kal szemben rezisztenssé vált gőmbatörzsek általelőidézett gőmbás megbetegedések is kezelhetők. ŕ
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9509631.9A GB9509631D0 (en) | 1995-05-12 | 1995-05-12 | Antifungal combination |
PCT/EP1996/002022 WO1996035423A1 (en) | 1995-05-12 | 1996-05-10 | Antifungal composition |
Publications (3)
Publication Number | Publication Date |
---|---|
HUP9801140A2 true HUP9801140A2 (hu) | 1999-01-28 |
HUP9801140A3 HUP9801140A3 (en) | 2000-07-28 |
HU224920B1 HU224920B1 (en) | 2006-04-28 |
Family
ID=10774361
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU9801140A HU224920B1 (en) | 1995-05-12 | 1996-05-10 | Use of an antifungal composition |
Country Status (26)
Country | Link |
---|---|
US (1) | US5985906A (hu) |
EP (1) | EP0824350B1 (hu) |
JP (1) | JPH11504931A (hu) |
KR (1) | KR100443535B1 (hu) |
CN (1) | CN1100539C (hu) |
AT (1) | ATE246504T1 (hu) |
AU (1) | AU712914B2 (hu) |
CA (1) | CA2219651C (hu) |
CY (1) | CY2496B1 (hu) |
CZ (1) | CZ291144B6 (hu) |
DE (1) | DE69629367T2 (hu) |
DK (1) | DK0824350T3 (hu) |
ES (1) | ES2205042T3 (hu) |
FI (1) | FI120079B (hu) |
GB (1) | GB9509631D0 (hu) |
HK (1) | HK1016064A1 (hu) |
HU (1) | HU224920B1 (hu) |
IL (2) | IL118219A (hu) |
MX (1) | MX9708699A (hu) |
NO (1) | NO317030B1 (hu) |
PL (1) | PL322749A1 (hu) |
PT (1) | PT824350E (hu) |
SK (1) | SK150797A3 (hu) |
TW (1) | TW464492B (hu) |
WO (1) | WO1996035423A1 (hu) |
ZA (1) | ZA963754B (hu) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6187757B1 (en) * | 1995-06-07 | 2001-02-13 | Ariad Pharmaceuticals, Inc. | Regulation of biological events using novel compounds |
CA2383451A1 (en) * | 1999-08-24 | 2001-03-01 | Ariad Gene Therapeutics, Inc. | 28-epirapalogs |
US7067526B1 (en) | 1999-08-24 | 2006-06-27 | Ariad Gene Therapeutics, Inc. | 28-epirapalogs |
GB0001315D0 (en) * | 2000-01-20 | 2000-03-08 | Novartis Ag | Organic compounds |
GB0003932D0 (en) * | 2000-02-18 | 2000-04-12 | Novartis Ag | Pharmaceutical compositions |
US6673373B2 (en) | 2001-02-01 | 2004-01-06 | Carlsbad Technology Inc. | Antifungal formulation and the methods for manufacturing and using the same |
US7244703B2 (en) | 2001-06-22 | 2007-07-17 | Bentley Pharmaceuticals, Inc. | Pharmaceutical compositions and methods for peptide treatment |
ATE457716T1 (de) | 2002-12-30 | 2010-03-15 | Angiotech Int Ag | Wirkstofffreisetzung von schnell gelierender polymerzusammensetzung |
EP1706128B1 (en) | 2003-12-08 | 2010-07-21 | CPEX Pharmaceuticals, Inc. | Pharmaceutical compositions and methods for insulin treatment |
US20060078580A1 (en) | 2004-10-08 | 2006-04-13 | Mediquest Therapeutics, Inc. | Organo-gel formulations for therapeutic applications |
US7740875B2 (en) * | 2004-10-08 | 2010-06-22 | Mediquest Therapeutics, Inc. | Organo-gel formulations for therapeutic applications |
ZA200708530B (en) | 2005-04-07 | 2009-04-29 | Toyama Chemical Co Ltd | Pharmaceutical composition and method using antifungal agent in combination |
BRPI0719157A2 (pt) | 2006-10-06 | 2014-02-04 | Toyama Chemical Co Ltd | Composição farmacêutica para o tratamento de infecções fúngicas, e, método de uso combinado para o tratamento de infecções fúngicas causadas por patógenos fúngicos. |
US20080167312A1 (en) * | 2006-12-08 | 2008-07-10 | Auspex Pharmaceuticals, Inc. | Preparation and utility of substituted allylamines |
WO2009089549A1 (en) | 2008-01-11 | 2009-07-16 | Massachusetts Eye & Ear Infirmary | Conditional-stop dimerizable caspase transgenic animals |
CN105283553B (zh) | 2013-06-11 | 2021-06-25 | 克隆技术实验室有限公司 | 蛋白质富集的微泡及其制备和使用方法 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4144346A (en) * | 1977-01-31 | 1979-03-13 | Janssen Pharmaceutica N.V. | Novel 1-(1,3-dioxolan-2-ylmethyl)-1H-imidazoles |
US4267179A (en) * | 1978-06-23 | 1981-05-12 | Janssen Pharmaceutica, N.V. | Heterocyclic derivatives of (4-phenylpiperazin-1-yl-aryloxymethyl-1,3-dioxolan-2-yl)methyl-1H-imidazoles and 1H-1,2,4-triazoles |
GB2099818A (en) * | 1981-06-06 | 1982-12-15 | Pfizer Ltd | Triazoles |
US4782059A (en) * | 1986-09-29 | 1988-11-01 | Merck & Co., Inc. | Method of controlling mycotic infections and compositions therefor |
JP2581707B2 (ja) * | 1987-10-02 | 1997-02-12 | 科研製薬株式会社 | 抗真菌剤組成物 |
CA2016738A1 (en) * | 1989-06-08 | 1990-12-08 | Philippe Guerry | Substituted aminoalkylbenzene derivatives |
JPH0338521A (ja) * | 1989-07-05 | 1991-02-19 | Maruho Kk | 抗真菌性組成物 |
JPH0338522A (ja) * | 1989-07-05 | 1991-02-19 | Maruho Kk | 抗真菌性組成物 |
US5214046A (en) * | 1989-07-27 | 1993-05-25 | Hoffmann-La Roche Inc. | Substituted aminoalkoxybenzene anti-fungicidal compositions and use |
CA2020888A1 (en) * | 1989-07-27 | 1991-01-28 | Philippe Guerry | Substituted aminoalkoxybenzene derivatives |
CA2044533A1 (en) * | 1990-06-29 | 1991-12-30 | Philippe Guerry | Substituted aminoalkylbiphenyl derivatives |
US5696164A (en) * | 1994-12-22 | 1997-12-09 | Johnson & Johnson Consumer Products, Inc. | Antifungal treatment of nails |
JP3038521U (ja) | 1996-12-05 | 1997-06-20 | 啓次 小峰 | 排泄物一時保持具用の水溶繊維製ステック状吸液材 |
JP3038522U (ja) | 1996-12-05 | 1997-06-20 | 秀俊 筬 | カード型紙箱ポプリ |
-
1995
- 1995-05-12 GB GBGB9509631.9A patent/GB9509631D0/en active Pending
-
1996
- 1996-05-10 SK SK1507-97A patent/SK150797A3/sk unknown
- 1996-05-10 AU AU58183/96A patent/AU712914B2/en not_active Ceased
- 1996-05-10 IL IL11821996A patent/IL118219A/xx not_active IP Right Cessation
- 1996-05-10 JP JP8533792A patent/JPH11504931A/ja active Pending
- 1996-05-10 DK DK96919769T patent/DK0824350T3/da active
- 1996-05-10 HU HU9801140A patent/HU224920B1/hu not_active IP Right Cessation
- 1996-05-10 KR KR1019970708050A patent/KR100443535B1/ko not_active IP Right Cessation
- 1996-05-10 WO PCT/EP1996/002022 patent/WO1996035423A1/en not_active Application Discontinuation
- 1996-05-10 PT PT96919769T patent/PT824350E/pt unknown
- 1996-05-10 MX MX9708699A patent/MX9708699A/es not_active IP Right Cessation
- 1996-05-10 ZA ZA9603754A patent/ZA963754B/xx unknown
- 1996-05-10 US US08/952,288 patent/US5985906A/en not_active Expired - Fee Related
- 1996-05-10 ES ES96919769T patent/ES2205042T3/es not_active Expired - Lifetime
- 1996-05-10 DE DE69629367T patent/DE69629367T2/de not_active Expired - Lifetime
- 1996-05-10 EP EP96919769A patent/EP0824350B1/en not_active Expired - Lifetime
- 1996-05-10 CN CN96193853A patent/CN1100539C/zh not_active Expired - Fee Related
- 1996-05-10 PL PL96322749A patent/PL322749A1/xx unknown
- 1996-05-10 CZ CZ19973547A patent/CZ291144B6/cs not_active IP Right Cessation
- 1996-05-10 AT AT96919769T patent/ATE246504T1/de not_active IP Right Cessation
- 1996-05-10 IL IL11821995A patent/IL118219A0/xx unknown
- 1996-05-10 TW TW085105532A patent/TW464492B/zh active
- 1996-05-10 CA CA002219651A patent/CA2219651C/en not_active Expired - Fee Related
-
1997
- 1997-09-26 FI FI973812A patent/FI120079B/fi not_active IP Right Cessation
- 1997-11-07 NO NO19975134A patent/NO317030B1/no not_active IP Right Cessation
-
1998
- 1998-12-10 HK HK98113058A patent/HK1016064A1/xx not_active IP Right Cessation
-
2004
- 2004-12-27 CY CY0400091A patent/CY2496B1/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP9801140A2 (hu) | Gombaellenes hatású kompozícíók, azok alkalmazása és előállítása, valamint gombafertőzések kezelése ilyen kompozíciókkal | |
BRPI0514199A (pt) | método de efetuar profilaxia ou tratar uma doença, composição farmacêutica, anticorpo monoclonal, célula de hibridoma, e, método de triar um agente, de humanizar anticorpo monoclonal 8a5 ou anticorpo monoclonal 6h7 e de produzir uma forma quimérica de anticorpo monoclonal 8a5 ou anticorpo monoclonal 6h7 | |
WO2002043652A3 (en) | Anti-proliferative drugs | |
MXPA02012272A (es) | Compuestos heterociclicos que son inhibidores de la enzima dipeptidilpeptidasa-iv. | |
NO20060307L (no) | Anvendelse av kinoazolinderivatet ZD6474 kombinert med platinaforbindelser og eventuelt ioniserende straling i behandling av sykdommer assosoiert med angiogenese og/eller okt vaskulaert permeabilitet | |
BR0212689A (pt) | Composição fungicida, método de controle e produto | |
TR200102809T2 (tr) | Bitki hastalıklarının kontrol edilmesi için bacillus pumilus soyu | |
WO2009020643A3 (en) | Method for inhibiting inflammation and pre-inflammatory cytokine/chemokine expression using a ghrelin analogue | |
HK1083196A1 (en) | Topical compositions having a natural ingredient and method of use | |
NO20045038L (no) | Kombinasjon av en beta-2 adrenoseptoragonist og et aminosukker og deres anvendelse ved behandling av immunomodulerende sykdommer | |
AU2001265151A1 (en) | Method of stimulating hair growth | |
MD1651F2 (en) | Fungi strains Nectria pityrodes Montagne possessing fungicidal properties and process for screening thereof, biofungicide, biofungicidal composition and method of fungicidal inhibition | |
NO20051261L (no) | Morfin-6-glukuronidsalt | |
ZA202104960B (en) | Methods of treating pain with a thiazoline anti-hyperalgesic | |
HK1087328A1 (en) | Therapeutic composition for autoimmune conditions | |
WO1999065475A3 (en) | Combination of phentolamine and apomorphine for the treatment of human sexual function and dysfunction | |
HUP9802419A2 (hu) | Antigén készítmények | |
WO2007008904A3 (en) | Targeting poly-gamma-glutamic acid to treat staphylococcus epidermidis and related infections | |
ATE157255T1 (de) | Zusammensetzung zur bekämpfung von dermatomykosen und deren erregern sowie von schweissbildung und körpergeruch | |
WO2019232203A3 (en) | Methods and compositions to alleviate vascular permeability | |
WO2022221834A3 (en) | Method for treating lung cancer and non-small cell lung cancer | |
MX2023002776A (es) | Glucoconjugados y usos medicos de los mismos. | |
ATE284209T1 (de) | Verwendung einer pharmazeutischen zusammensetzung zur herstellung eines medikamentes zur behandlung von durch bakterien, viren, pilze, hefen und/oder protozoen verursachten augenerkrankungen | |
MX2022012001A (es) | Tratamiento preventivo de la migra?a. | |
MX2021015796A (es) | Composiciones y metodos para tratar enfermedades oculares. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FH91 | Appointment of a representative |
Free format text: FORMER REPRESENTATIVE(S): DANUBIA SZABADALMI ES VEDJEGY IRODA KFT., HU Representative=s name: DERZSI KATALIN, S.B.G. & K. BUDAPESTI NEMZETKO, HU |
|
FH92 | Termination of representative |
Representative=s name: DANUBIA SZABADALMI ES VEDJEGY IRODA KFT., HU |
|
MM4A | Lapse of definitive patent protection due to non-payment of fees |